Financhill
Back

Cerevel Therapeutics Holdings Stock Price Chart

Master the Market: The Formula for a 96.3% Win Rate Revealed!

Act now!
Buy
55

CERE
Cerevel Therapeutics Holdings

Last Price:
41.56
Seasonality Move:
28.79%

7 Day Trial

ALL ACCESS PASS

$ 7

Will Crypto Make People Rich Again Starting April 2024?

Details on how to profit here.
  • The current trend is moderately bearish and CERE is experiencing selling pressure, which indicates risk of future bearish movement.

Cerevel Therapeutics Holdings Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 41.94 Sell
20-day SMA: 42.16 Sell
50-day SMA: 41.92 Sell
200-day SMA: 32.43 Buy
8-day EMA: 41.85 Sell
20-day EMA: 42 Sell
50-day EMA: 41.51 Sell
200-day EMA: 35.54 Buy

Cerevel Therapeutics Holdings Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 30.52 Sell
Chaikin Money Flow: -831356 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.93 - 42.43) Sell
Bollinger Bands (100): (35.69 - 45.07) Buy

Cerevel Therapeutics Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Cerevel Therapeutics Holdings Stock

Is Cerevel Therapeutics Holdings Stock a Buy?

CERE Technical Analysis vs Fundamental Analysis

Buy
55
Cerevel Therapeutics Holdings (CERE) is a Buy

Is Cerevel Therapeutics Holdings a Buy or a Sell?

Cerevel Therapeutics Holdings Stock Info

Market Cap:
7.5B
Price in USD:
41.31
Share Volume:
1.39M

Cerevel Therapeutics Holdings 52-Week Range

52-Week High:
43.59
52-Week Low:
19.59
Buy
55
Cerevel Therapeutics Holdings (CERE) is a Buy

Cerevel Therapeutics Holdings Share Price Forecast

Is Cerevel Therapeutics Holdings Stock a Buy?

Fundamental Analysis of Cerevel Therapeutics Holdings

Is Cerevel Therapeutics Holdings a good investment?

  • Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and a decrease next year of $0.32 per share.

Technical Analysis of Cerevel Therapeutics Holdings

Should I short Cerevel Therapeutics Holdings stock?

* Cerevel Therapeutics Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.